Enzo Biochem Inc (ENZ) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Apr 30 2025 to Apr 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Enzo Biochem Inc  (NYSE: ENZ)


Enzo Biochem Inc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Enzo Biochem Inc's ROI in the third quarter of 2025?
Enzo Biochem Inc recorded a cumulative net loss of $-21 million during 12 months ending in the third quarter of 2025, resulting in a negative return on investment (ROI) of -41.04%.

Within the Healthcare sector 488 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2025 from 3341 to 3413.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Apr 30 2025)
III. Quarter		 (Jan 31 2025)
II. Quarter		 (Oct 31 2024)
I. Quarter		 (Jul 31 2024)
IV. Quarter		 (Apr 30 2024)
III. Quarter
Y / Y Investment Change TTM -30.58 % -9.53 % 11.1 % 37.42 % 62.9 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 47 48 50 60 72
Return On Investment (TTM) -41.04 % -37.08 % -36.16 % -37.6 % 60.44 %
ENZ's Overall Ranking # 3413 # 3341 # 66 # #
Seq. Investment Change TTM -10.62 % -8.99 % -8.94 % -6.28 % 16.49 %
Seq. Net Income Change TTM - - - - 37.36 %
Net Income (TTM) in Millions -21 -21 -23 -26 45

ENZ Company Profile >> Back to ENZ Roi Comparisons >> See Annual ENZ Return On Investment



Return On Investment ENZ's Ranking
Within: No.
Industry # 69
Sector # 489
Overall # 3413

Return On Investment Statistics
High Average Low
71.32 %
-5.31 %
-79.86 %
(Jul 31 2016)   (Apr 30 2023)







Financial Statements
Enzo Biochem Inc's III. Quarter Investments $ 47 Millions ENZ's Balance sheet
Enzo Biochem Inc's III. Quarter Income $ -3 Millions Quarterly ENZ's Income Statement
ENZ's Income by Division See ENZ's Income by Division


ENZ Annual Return On Investment (Jul 31 2024)
2024		 (Jul 31 2023)
2023		 (Jul 31 2022)
2022		 (Jul 31 2021)
2021		 (Jul 31 2020)
2020
Total Investments in Millions 60 79 59 73 63
Y / Y Investment Growth -23.63 % 34.4 % -19.82 % 15.86 % -30.42 %
Net Income in Millions -26 20 -18 8 -29
Y / Y Net Income Growth - - - - -
Annual Return On Investment -43.37 % 25.77 % -31.17 % 10.78 % -45.23 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ENZ's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ENZ's Competitors
Subscribers only: Roi for Enzo Biochem Inc's Suppliers
Subscribers only: Return On Investment for ENZ's Customers

Other Ratios
ENZ's Roa ENZ's Inventory Turnover Ratio ENZ's Growth Rates ENZ's Dividend Statistics
ENZ's Profitability Ratios ENZ's Asset Turnover Ratio ENZ's Dividend Growth
ENZ's Roe ENZ's Valuation Ratios ENZ's Financial Strength Ratios ENZ's Dividend Payout Ratio



Companies with similar Return On Investment at Apr 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-08T17:35:01+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.